Alnara Pharmaceuticals Inc. is expected to announce Thursday morning the close of a $35 million Series B financing, which will support launch preparations for pancreatic enzyme replacement therapy (PERT) liprotamase. (BioWorld Today)

SAN FRANCISCO - A short-lived drizzle early Tuesday morning failed to dissuade attendees at the 28th annual J.P. Morgan Healthcare conference from turning out to hear biotech behemoths like Genzyme Corp. and Amgen Inc. preview year-end earnings and outline plans for addressing the challenges that have plagued them of late. (BioWorld Today)